Expanding the therapeutic role of highly purified cannabidiol in monogenic epilepsies: A multicenter real‐world study

This study supports CBD as a potential treatment for monogenic epilepsies beyond its licensed indications, demonstrating comparable effectiveness between approved and off-label use and suggesting genetic subgroups with promising treatment responses.

Authors

Institutions

Publication Details

Journal
Epilepsia
Published
2025-03-24
DOI
https://doi.org/10.1111/epi.18378
Citations
9
Primary Topic
Cannabis and Cannabinoid Research
Type
article
Field-Weighted Citation Impact
12.55
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Expanding the therapeutic role of highly purified cannabidiol in monogenic epilepsies: A multicenter real‐world study

Alia Ramírez-Camacho, Luca Bergonzini, Giulia Prato, Francesca Bisulli et al.
9 citations
Epilepsia
Cannabis and Cannabinoid Research
12.55
article

Expanding the therapeutic role of highly purified cannabidiol in monogenic epilepsies: A multicenter real‐world study

Alia Ramírez-Camacho, Luca Bergonzini, Giulia Prato, Francesca Bisulli, Elena Gardella, Domenica Battaglia, Maria Margherita Mancardi, Duccio Maria Cordelli, Gabriela Reyes Valenzuela, Ángel Aledo‐Serrano, Jana Domínguez‐Carral, Roberto Caraballo, Emanuele Cerulli Irelli, Andrea Rüegger, Antonella Riva, Georgia Ramantani, Javier Peña‐Ceballos, Patrick B. Moloney, Alessandro Ascani Orsini, Elisabetta Cesaroni, Adolfo Mazzeo, Marco Perulli, Francesca Felicia Operto, Valentina De Giorgis, Antonietta Coppola, Paolo Bonanni, Laura Licchetta, Sara Matricardi, Carlo Di Bonaventura, Pasquale Striano, Carla Marini, Giancarlo Di Gennaro, Katarzyna Maria Mieszczanek, Andrea Santangelo, G Santangelo, Alessandro Ferretti, Marica Rubino, Norman Delanty, Susanna Casellato
article en
9 citations

Abstract

This study supports CBD as a potential treatment for monogenic epilepsies beyond its licensed indications, demonstrating comparable effectiveness between approved and off-label use and suggesting genetic subgroups with promising treatment responses.

EpilepsiaVol. 66(7)
University of Pisa (IT), Hospital Sant Joan de Déu Barcelona (ES), Royal College of Surgeons in Ireland (IE), University of Sassari (IT), University of Southern Denmark (DK), University of Pavia (IT), Garrahan Hospital (AR), Istituto Giannina Gaslini (IT), Beaumont Hospital (IE), Agostino Gemelli University Polyclinic (IT), Mater Misericordiae University Hospital (IE), Istituto Neurologico Mediterraneo (IT), University of Chieti-Pescara (IT), Azienda Ospedaliero Universitaria di Sassari (IT), CTO Andrea Alesini (IT), Istituto delle Scienze Neurologiche di Bologna (IT), University Children's Hospital Zurich (CH), Azienda di Rilievo Nazionale ed Alta Specializzazione (IT), IRCCS Eugenio Medea (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Institut de Recerca Sant Joan de Déu, University of Naples Federico II (IT), University of Genoa (IT), Sapienza University of Rome (IT), University of Bologna (IT)
Openalex Percentile: Top 1%
Cannabis and Cannabinoid Research
12.55
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.